The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Fridriksdottir Hafrun since year 2005.
The trader's CIK number is 1561458.
At the time of this reporting, Fridriksdottir Hafrun is the Executive VP, Global R&D of Teva Pharmaceutical Industries Ltd .
(stock ticker symbol TEVA).
See this page for all insider trading activities at Teva Pharmaceutical Industries Ltd .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-31||TEVA||Teva Pharmaceutical Industries Ltd||Option Ex||4,640||.00||0|
|2019-01-02||TEVA||Teva Pharmaceutical Industries Ltd||Sale||1,643||15.70||25,800|
|2018-11-30||TEVA||Teva Pharmaceutical Industries Ltd||Sale||933||21.76||20,303|
|2018-11-30||TEVA||Teva Pharmaceutical Industries Ltd||Option Ex||2,711||.00||0|
|2018-03-19||TEVA||Teva Pharmaceutical Industries Ltd||Sale||348||17.88||6,221|
|2018-03-17||TEVA||Teva Pharmaceutical Industries Ltd||Option Ex||1,012||.00||0|
|2018-03-05||TEVA||Teva Pharmaceutical Industries Ltd||Option Ex||3,432||.00||0|
|2018-03-04||TEVA||Teva Pharmaceutical Industries Ltd||Option Ex||1,165||.00||0|
|2013-09-30||ACT||Watson Pharmaceuticals Inc||Option Ex||5,110||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fridriksdottir Hafrun (Executive VP, Global R&D of Teva Pharmaceutical Industries Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.